Genetic engineering of transfusable platelets with mRNA-lipid nanoparticles is compatible with blood banking practices

2.

van der Meijden

PEJ

,

Heemskerk

JWM

.

Platelet biology and functions: new concepts and clinical perspectives

.

Nat Rev Cardiol

.

2019

;

16

(

3

):

166

-

179

.

3.

Shi

Q

,

Kuether

EL

,

Chen

Y

,

Schroeder

JA

,

Fahs

SA

,

Montgomery

RR

.

Platelet gene therapy corrects the hemophilic phenotype in immunocompromised hemophilia A mice transplanted with genetically manipulated human cord blood stem cells

.

Blood

.

2014

;

123

(

3

):

395

-

403

.

4.

Du

LM

,

Nurden

P

,

Nurden

AT

, et al.

Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A

.

Nat Commun

.

2013

;

4

:

2773

.

5.

Charlesworth

CT

,

Hsu

I

,

Wilkinson

AC

,

Nakauchi

H

.

Immunological barriers to haematopoietic stem cell gene therapy

.

Nat Rev Immunol

.

2022

;

22

(

12

):

719

-

733

.

6.

Leung

J

,

Strong

C

,

Badior

KE

, et al.

Genetically engineered transfusable platelets using mRNA lipid nanoparticles

.

Sci Adv

.

2023

;

9

(

48

):

eadi0508

.

7.

Leung

J

,

Cau

MF

,

Kastrup

CJ

.

Emerging gene therapies for enhancing the hemostatic potential of platelets

.

Transfusion

.

2021

;

61

(

suppl 1

):

S275

-

S285

.

8.

Weyrich

AS

,

Schwertz

H

,

Kraiss

LW

,

Zimmerman

GA

.

Protein synthesis by platelets: historical and new perspectives

.

J Thromb Haemost

.

2009

;

7

(

2

):

241

-

246

.

9.

Akinc

A

,

Maier

MA

,

Manoharan

M

, et al.

The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs

.

Nat Nanotechnol

.

2019

;

14

(

12

):

1084

-

1087

.

10.

Polack

FP

,

Thomas

SJ

,

Kitchin

N

, et al.

Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine

.

N Engl J Med

.

2020

;

383

(

27

):

2603

-

2615

.

11.

Baden

LR

,

El Sahly

HM

,

Essink

B

, et al.

Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine

.

N Engl J Med

.

2021

;

384

(

5

):

403

-

416

.

12.

Sato

Y

,

Hashiba

K

,

Sasaki

K

,

Maeki

M

,

Tokeshi

M

,

Harashima

H

.

Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo

.

J Control Release

.

2019

;

295

:

140

-

152

.

13.

Chander

N

,

Basha

G

,

Yan Cheng

MH

,

Witzigmann

D

,

Cullis

PR

.

Lipid nanoparticle mRNA systems containing high levels of sphingomyelin engender higher protein expression in hepatic and extra-hepatic tissues

.

Mol Ther Methods Clin Dev

.

2023

;

30

:

235

-

245

.

14.

Walkowiak

B

,

Kralisz

U

,

Michalec

L

, et al.

Comparison of platelet aggregability and P-selectin surface expression on platelets isolated by different methods

.

Thromb Res

.

2000

;

99

(

5

):

495

-

502

.

15.

Siewiera

K

,

Labieniec-Watala

M

,

Wolska

N

,

Kassassir

H

,

Watala

C

.

Sample preparation as a critical aspect of blood platelet mitochondrial respiration measurements-the impact of platelet activation on mitochondrial respiration

.

Int J Mol Sci

.

2021

;

22

(

17

):

9332

.

16.

Spelmink

SE

,

Jager

ST

,

van de Watering

L

, et al.

Efficacy and safety of platelet additive solution-E stored platelet concentrates

.

Transfusion

.

2023

;

63

(

12

):

2273

-

2280

.

17.

van der Meer

PF

,

de Korte

D

.

Platelet additive solutions: a review of the latest developments and their clinical implications

.

Transfus Med Hemother

.

2018

;

45

(

2

):

98

-

102

.

18.

Tobian

AA

,

Fuller

AK

,

Uglik

K

, et al.

The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME)

.

Transfusion

.

2014

;

54

(

6

):

1523

-

1529

. quiz 1522.

19.

Devine

DV

,

Serrano

K

.

The platelet storage lesion

.

Clin Lab Med

.

2010

;

30

(

2

):

475

-

487

.

20.

Strandenes

G

,

Sivertsen

J

,

Bjerkvig

CK

, et al.

A pilot trial of platelets stored cold versus at room temperature for complex cardiothoracic surgery

.

Anesthesiology

.

2020

;

133

(

6

):

1173

-

1183

.

21.

Center for Biologics Evaluation and Research

. Alternative Procedures for the Manufacture of Cold-Stored Platelets Intended for the Treatment of Active Bleeding when Conventional Platelets Are Not Available or Their Use Is Not Practical.

U.S. Department of Health and Human Services Food and Drug Administration

;

2023

.

22.

Levin

E

,

Culibrk

B

,

Gyongyossy-Issa

MI

, et al.

Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production

.

Transfusion

.

2008

;

48

(

11

):

2331

-

2337

.

23.

Circular of Information For the Use of Human Blood Components

.

Canadian Blood Services

.

2022

.

24.

Blais-Normandin

I

,

Tordon

B

,

Anani

W

,

Ning

S

. Pathogen-reduced platelets. In:

Khandelwal

A

,

Abe

T

, eds.

Clinical Guide to Transfusion

.

Ottawa

:

Canadian Blood Services

;

2022

. chap 19.

25.

Kulkarni

JA

,

Witzigmann

D

,

Leung

J

, et al.

Fusion-dependent formation of lipid nanoparticles containing macromolecular payloads

.

Nanoscale

.

2019

;

11

(

18

):

9023

-

9031

.

26.

Kulkarni

JA

,

Cullis

PR

,

van der Meel

R

.

Lipid nanoparticles enabling gene therapies: from concepts to clinical utility

.

Nucleic Acid Ther

.

2018

;

28

(

3

):

146

-

157

.

27.

World Intellectual Property Organization

. Mc3-type lipids and use thereof in the preparation of lipid nanoparticles. In:

Ciufolini

MA

,

Kulkarni

J

,

Kurek

D

,

Saadati

F

,

Tam

AC

,

Witzigmann

, eds.

Patent application WO 2022/246571 A1

.

2022

.

28.

Adams

D

,

Gonzalez-Duarte

A

,

O'Riordan

WD

, et al.

Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis

.

N Engl J Med

.

2018

;

379

(

1

):

11

-

21

.

29.

Jayaraman

M

,

Ansell

SM

,

Mui

BL

, et al.

Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo

.

Angew Chem Int Ed Engl

.

2012

;

51

(

34

):

8529

-

8533

.

30.

Cheng

MHY

,

Leung

J

,

Zhang

Y

, et al.

Induction of bleb structures in lipid nanoparticle formulations of mRNA leads to improved transfection potency

.

Adv Mater

.

2023

;

35

(

31

):

e2303370

.

31.

Hald Albertsen

C

,

Kulkarni

JA

,

Witzigmann

D

,

Lind

M

,

Petersson

K

,

Simonsen

JB

.

The role of lipid components in lipid nanoparticles for vaccines and gene therapy

.

Adv Drug Deliv Rev

.

2022

;

188

:

114416

.

32.

Schoenmaker

L

,

Witzigmann

D

,

Kulkarni

JA

, et al.

mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability

.

Int J Pharm

.

2021

;

601

:

120586

.

33.

Morton

LF

,

Hargreaves

PG

,

Farndale

RW

,

Young

RD

,

Barnes

MJ

.

Integrin alpha 2 beta 1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for alpha 2 beta 1-independent platelet reactivity

.

Biochem J

.

1995

;

306

(

Pt 2

):

337

-

344

.

34.

De Simone

I

,

Baaten

C

,

Gibbins

JM

, et al.

Repeated platelet activation and the potential of previously activated platelets to contribute to thrombus formation

.

J Thromb Haemost

.

2023

;

21

(

5

):

1289

-

1306

.

35.

Dachary-Prigent

J

,

Freyssinet

JM

,

Pasquet

JM

,

Carron

JC

,

Nurden

AT

.

Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups

.

Blood

.

1993

;

81

(

10

):

2554

-

2565

.

36.

Sodergren

AL

,

Ramstrom

S

.

Platelet subpopulations remain despite strong dual agonist stimulation and can be characterised using a novel six-colour flow cytometry protocol

.

Sci Rep

.

2018

;

8

(

1

):

1441

.

37.

Tyagi

T

,

Jain

K

,

Gu

SX

, et al.

A guide to molecular and functional investigations of platelets to bridge basic and clinical sciences

.

Nat Cardiovasc Res

.

2022

;

1

(

3

):

223

-

237

.

38.

Vadgama

A

,

Boot

J

,

Dark

N

, et al.

Multiparameter phenotyping of platelets and characterization of the effects of agonists using machine learning

.

Res Pract Thromb Haemost

.

2024

;

8

(

5

):

102523

.

39.

Spurgeon

BEJ

,

Frelinger

AL

.

Comprehensive phenotyping of human platelets by single-cell cytometry

.

Cytometry A

.

2022

;

101

(

4

):

290

-

297

.

40.

Görlinger

K

,

Dirkmann

D

,

Hanke

AA

. Rotational thromboelastometry (ROTEM®). In:

Gonzalez

E

,

Moore

HB

,

Moore

EE

, eds.

Trauma Induced Coagulopathy

.

Springer International Publishing

;

2016

:

267

-

298

.

41.

Zhao

H

,

Devine

DV

.

The missing pieces to the cold-stored platelet puzzle

.

Int J Mol Sci

.

2022

;

23

(

3

):

1100

.

42.

New

HV

,

Berryman

J

,

Bolton-Maggs

PH

, et al.

Guidelines on transfusion for fetuses, neonates and older children

.

Br J Haematol

.

2016

;

175

(

5

):

784

-

828

.

43.

Devine

DV

.

Novel platelet products including cold-stored platelets

.

Hematology Am Soc Hematol Educ Program

.

2022

;

2022

(

1

):

421

-

423

.

44.

Tobian

AA

,

Savage

WJ

,

Tisch

DJ

,

Thoman

S

,

King

KE

,

Ness

PM

.

Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction

.

Transfusion

.

2011

;

51

(

8

):

1676

-

1683

.

45.

Francia

V

,

Schiffelers

RM

,

Cullis

PR

,

Witzigmann

D

.

The biomolecular corona of lipid nanoparticles for gene therapy

.

Bioconjug Chem

.

2020

;

31

(

9

):

2046

-

2059

.

46.

Dilliard

SA

,

Cheng

Q

,

Siegwart

DJ

.

On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles

.

Proc Natl Acad Sci U S A

.

2021

;

118

(

52

):

e2109256118

.

47.

Zhang

R

,

El-Mayta

R

,

Murdoch

TJ

, et al.

Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver

.

Biomater Sci

.

2021

;

9

(

4

):

1449

-

1463

.

48.

Hafez

IM

,

Maurer

N

,

Cullis

PR

.

On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids

.

Gene Ther

.

2001

;

8

(

15

):

1188

-

1196

.

49.

Kulkarni

JA

,

Myhre

JL

,

Chen

S

, et al.

Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA

.

Nanomedicine

.

2017

;

13

(

4

):

1377

-

1387

.

50.

Seynhaeve

ALB

,

Dicheva

BM

,

Hoving

S

,

Koning

GA

,

Ten Hagen

TLM

.

Intact Doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: evaluated by in vitro/in vivo live cell imaging

.

J Control Release

.

2013

;

172

(

1

):

330

-

340

.

51.

Mui

BL

,

Tam

YK

,

Jayaraman

M

, et al.

Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles

.

Mol Ther Nucleic Acids

.

2013

;

2

(

12

):

e139

.

52.

Hayashi

Y

,

Takenaka

S

,

Kohmura

C

,

Ikeda

H

.

Preparation of discoid washed platelets by differential centrifugation

.

Clin Chim Acta

.

1998

;

275

(

1

):

99

-

105

.

53.

Omo-Lamai

S

,

Zamora

ME

,

Patel

MN

, et al.

Physicochemical targeting of lipid nanoparticles to the lungs induces clotting: mechanisms and solutions

.

Adv Mater

.

2024

;

36

(

26

):

e2312026

.

54.

Golebiewska

EM

,

Poole

AW

.

Platelet secretion: from haemostasis to wound healing and beyond

.

Blood Rev

.

2015

;

29

(

3

):

153

-

162

.

55.

de Wit

YES

,

Vlaar

R

,

Gouwerok

E

, et al.

Platelet concentrates in platelet additive solutions generate less complement activation products during storage than platelets stored in plasma

.

Blood Transfus

.

2023

;

21

(

2

):

157

-

167

.

56.

Thon

JN

,

Devine

DV

.

Translation of glycoprotein IIIa in stored blood platelets

.

Transfusion

.

2007

;

47

(

12

):

2260

-

2270

.

57.

Ng

MSY

,

Tung

JP

,

Fraser

JF

.

Platelet storage lesions: what more do we know now?

.

Transfus Med Rev

.

2018

;

32

(

3

):

144

-

154

.

58.

Mills

EW

,

Green

R

,

Ingolia

NT

.

Slowed decay of mRNAs enhances platelet specific translation

.

Blood

.

2017

;

129

(

17

):

e38

-

e48

.

59.

Mills

EW

,

Wangen

J

,

Green

R

,

Ingolia

NT

.

Dynamic regulation of a ribosome rescue pathway in erythroid cells and platelets

.

Cell Rep

.

2016

;

17

(

1

):

1

-

10

.

60.

Pienimaeki-Roemer

A

,

Kuhlmann

K

,

Bottcher

A

, et al.

Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets

.

Transfusion

.

2015

;

55

(

3

):

507

-

521

.

61.

Green

SM

,

Padula

MP

,

Dodgen

TM

,

Batarseh

A

,

Marks

DC

,

Johnson

L

.

Lipidomic changes occurring in platelets during extended cold storage

.

Transfus Med

.

2024

;

34

(

3

):

189

-

199

.

62.

Cardigan

R

,

Williamson

LM

.

The quality of platelets after storage for 7 days

.

Transfus Med

.

2003

;

13

(

4

):

173

-

187

.

63.

Kufrin

D

,

Eslin

DE

,

Bdeir

K

, et al.

Antithrombotic thrombocytes: ectopic expression of urokinase-type plasminogen activator in platelets

.

Blood

.

2003

;

102

(

3

):

926

-

933

.

64.

Schiffer

CA

,

Bohlke

K

,

Delaney

M

, et al.

Platelet transfusion for patients with cancer: American Society of Clinical Oncology clinical practice guideline update

.

J Clin Oncol

.

2018

;

36

(

3

):

283

-

299

.

65.

Haemmerle

M

,

Stone

RL

,

Menter

DG

,

Afshar-Kharghan

V

,

Sood

AK

.

The platelet lifeline to cancer: challenges and opportunities

.

Cancer Cell

.

2018

;

33

(

6

):

965

-

983

.